<DOC>
	<DOCNO>NCT00076687</DOCNO>
	<brief_summary>The purpose study evaluate safety injection botulinum toxin Type A patient reduced lung function focal upper limb poststroke spasticity</brief_summary>
	<brief_title>Safety Study Botulinum Toxin Type A Post-Upper Limb Stroke Patients With Reduced Lung Function</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Abnormal pulmonary function test result ; focal , upper limb spasticity , upper motor neuron syndrome Previous exposure botulinum toxin serotype</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>